Skip to main content

Advertisement

SpringerLink
Log in

Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: Patterns, user characteristics, and management options

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

The nonmedical use of scheduled medications commonly prescribed for pain, pain-related symptoms, and psychiatric disorders began rising in the mid-1990s. Physicians are confronted with the dilemma of how to minimize the abuse and diversion potential of these products without compromising access for patients with a legitimate medical need. Using data from the National Survey on Drug Use and Health, we describe the scope of nonmedical use of opioids, stimulants, and tranquilizers; characteristics of nonmedical users; and options available to reduce abuse liability. In 2003, lifetime prevalence estimates of nonmedical use were 31.2 million for opioids, 20.7 million for stimulants, and 20.2 million for tranquilizers. Nonmedical users of psychotherapeutics were more likely to be Caucasian; use alcohol, cocaine, or heroin; and to use needles to inject drugs than those who reported using illicit drugs only. Sources of diversion are enumerated, and options for minimizing the abuse liability associated with these medications are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Goodwin RD, Hasin DS: Sedative use and misuse in the United States. Addiction 2002, 97:555–562.

    Article  PubMed  Google Scholar 

  2. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774). Rockville, MD, 2003.

  3. Substance Abuse and Mental Health Services Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964). Rockville, MD, 2004.

  4. Zacny J, Bigelow G, Compton P, et al.: College on problems of drug dependence task force on prescription opioid nonmedical us and abuse: position statement. Drug Alcohol Depend 2003, 69:215–232. The authors urge balance between risk management strategies and appropriate access to pharmacotherapy for the treatment of pain.

    Article  PubMed  Google Scholar 

  5. National Institute on Drug Abuse. NIDA and partners announce national initiative on prescription drug misuse. NIDA, National Institutes of Health, U.S. Department of Health and Human Services; Bethesda, MD. News release issued April 10, 2001. Available at www.drugabuse.gov/MedAdv/01/ NR4-10.html.

  6. Manchikanti L, Fellows B, Damron KS, et al.: Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. Journal of the Kentucky Medical Association 2005, 103:55–62.

    PubMed  Google Scholar 

  7. Williams RJ, Goodale LA, Shay-Fiddler MA, et al.: Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents. Am J Addict 2004, 13:381–89.

    Article  PubMed  Google Scholar 

  8. Zarba A, Storr CL, Wagner FA: Carrying habits into old age: prescription drug use without medical advice by older American adults. J Am Geriatr Soc 2005, 53:170–171.

    Article  PubMed  Google Scholar 

  9. Hall KM, Irwin MM, Bowman KA, et al.: Illicit use of prescribed stimulant medication among college students. J Am Coll Health 2005, 53:167–174.

    Article  PubMed  Google Scholar 

  10. Clark RE, Xie H, Brunette MF: Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry 2004, 65:151–152.

    Article  PubMed  Google Scholar 

  11. McCabe SE, Teter CJ, Boyd CJ, et al.: Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey. Addict Behav 2005, 30:789–805.

    Article  PubMed  Google Scholar 

  12. Young D: Federal reports say oxycodone abuse is on the rise. Am J Health Syst Pharm 2001, 58:1175,1178–1179.

    Google Scholar 

  13. Office of National Drug Control Policy 2005. http://www.whitehousedrugpolicy.gov/publications/policy/ ndcs05/ndcs.pdf.

  14. Cicero TJ, Adams EH, Geller A, et al.: A post-marketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Abuse 1999, 57:7–22.

    CAS  Google Scholar 

  15. Arfken CL, Schuster CR, Johanson CE: Postmarketing surveillance of abuse liability of Sibutramine. Drug Alcohol Depend 2003, 69:169–173.

    Article  PubMed  Google Scholar 

  16. World Health Organization: Cancer Pain Relief, Second Edition with a Guide to Opioid Availability, Cancer Pain Relief and Palliative Care: Report of the WHO Expert Committee (WHO Technical Report Series, No. 804). Geneva: WHO; 1996.

    Google Scholar 

  17. Gilson AM, Ryan KM, Joranson DE, et al.: A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage 2004, 28:176–188.

    Article  PubMed  Google Scholar 

  18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000:247.

    Google Scholar 

  19. Physicians’ Desk Reference, 2005.

  20. DiSio JM, Bacon DR, Peer G, et al.: Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient. Anesthesiology 1993, 79:1139–1141.

    Article  Google Scholar 

  21. Meier B: Painkiller: A “wonder” Drug’s Trail of Addiction and Death. New York: Rodale Press; 2003.

    Google Scholar 

  22. Brookoff D: Abuse potential of various opioid medications. J Gen Intern Med 1993, 8:688–690.

    Article  PubMed  CAS  Google Scholar 

  23. Auriacombe M, Franques P, Tignol J: Deaths attributable to methadone vs. buprenorphine in France. JAMA 2001, 285:35.

    Article  Google Scholar 

  24. Graham A, Smith MY, Haddox JD, et al.: Reducing the potential for diversion of prescription opioids: Tested interventions. Poster presented at College on Problems of Drug Dependence, Orlando, Florida, June 2005.

  25. Forman R, Woody G, McLellan T: Availability of websites offering to sell opioid-containing medications without a prescription. Am J Psychiatry In press, 2005.

  26. Joranson DE, Carrow GM, Ryan KM, et al.: Pain management and prescription monitoring. J Pain Symptom Manage 2002, 23:231–238. The authors report on prescription monitoring programs as a strategy agains diversion of prescription drugs.

    Article  PubMed  Google Scholar 

  27. Fudala P, Woody GE: Current and experimental therapeutics for opioid addiction. In Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT. Philadelphia: Lippincott, Williams & Wilkins; 2002:1507–1518.

    Google Scholar 

  28. Woody GE: Psychosocial and pharmacologic treatment of substance abuse disorders. In The Science, Treatment and Prevention of Antisocial Behaviors. Edited by Fishbein DH. Kingston, NJ: Civic Research Institute; 2000. This is an important work dealing with two components of treatment in substance abuse disorders.

    Google Scholar 

  29. Cone EJ, Fant RV, Rohay JM, et al.: Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. J Anal Toxicol 2004, 28:616–624.

    PubMed  CAS  Google Scholar 

  30. Miller S, Greenfeld A: Patient characteristics and risks factors for development of dependence on hydrocodone and oxycodone. Am J Ther 2004, 11:26–32.

    Article  PubMed  Google Scholar 

  31. Woody G, O’Brien CP, Greenstein RA: Misuse and abuse of diazepam: an increasingly common medical problem. Int J Addict 1975, 10:843–848.

    PubMed  CAS  Google Scholar 

  32. Potter JS, Hennessy G, Borrow JA, et al.: Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend 2004, 76:213–215.

    Article  PubMed  Google Scholar 

  33. Simoni-Wastila L, Ritter G, Strickler G: Gender and other factors associated with the nonmedical use of abusable prescription drugs. Substance Use Misuse 2004, 39:1–23.

    Article  PubMed  Google Scholar 

  34. Simoni-Wastila L: The use of abusable prescription drugs: The role of gender. J Womens Health Gender Based Med 2000, 9:289–297.

    Article  CAS  Google Scholar 

  35. Simoni-Wastila L, Strickler G: Risk factors associated with problem use of prescription drugs. Am J Pub Health 2004, 94:266–268. This paper found the greatest risk in older adults, females, those in poor/fair health, and people who consume alcohol on a daily basis.

    Article  PubMed  Google Scholar 

  36. Johnston LD, O’Malley PM, Bachman JG, et al.: Monitoring the Future national results on adolescent drug use: Overview of Key Findings, 2004. (NIH:Publication No. 04-5506). Bethesda, MD: National Institute on Drug Abuse, 2005.

    Google Scholar 

  37. Gfroerer J, Wright D, Kopstein A: Prevalence of youth substance use: the impact of methodological differences between two national surveys. Drug Alcohol Depend 1997, 47:19–30. Using two major, federally funded surveys, the authors concluded that methodologic differences in survey design can have a significant impact on prevalence estimates.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Purdue Pharma, L.P., One Stamford Forum, 06901, Stamford, CT, USA

    Meredith Y. Smith PhD, MPA

Authors
  1. Meredith Y. Smith PhD, MPA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Woody MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M.Y., Woody, G. Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: Patterns, user characteristics, and management options. Curr Psychiatry Rep 7, 337–343 (2005). https://doi.org/10.1007/s11920-005-0033-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-005-0033-4

Keywords

Search

Navigation